Cipla’s arm inks definitive agreement to sell 100% stake in Four M Propack

19 Jan 2017 Evaluate

Cipla’s wholly owned subsidiary - Goldencross Pharma has entered in to a definitive agreement to sell its 100% equity stake in Four M Propack, India (Four M Propack) to Shriji Polymers (India) (Shriji Polymers) for a consideration of Rs 13.5 crore and an additional sum derived on the basis of the value of mutual funds, cash and bank balance, tax refunds, etc. at the time of closing estimated at around Rs 5.7 crore.

The transaction is expected to be completed within 45 days from date of signing of the definitive agreement, subject to completion of certain condition precedent and receipt of applicable approvals.

Shriji Polymers is engaged in the business of manufacturing of HDPE bottles and PP caps for the pharmaceutical industry.


Cipla Share Price

1351.85 4.20 (0.31%)
02-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1752.70
Dr. Reddys Lab 1294.65
Cipla 1351.85
Zydus Lifesciences 906.85
Lupin 2311.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×